Patents by Inventor KANNAN MURUGAN

KANNAN MURUGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR ASYMMETRICAL PEER FORWARDING IN AN SD-WAN ENVIRONMENT
    Publication number: 20240080267
    Abstract: In one embodiment, a method includes receiving, by a first node of a node cluster in a software-defined wide area network (SD-WAN), traffic from a wide area network (WAN), assigning, by the first node of the node cluster, flow ownership of the traffic to the first node, and communicating, by the first node of the node cluster, the traffic to a local area network (LAN). The method also includes receiving, by the first node of the node cluster, return traffic from a second node of the node cluster and detecting, by the first node of the node cluster, a diversion of the return traffic. The method further includes relinquishing, by the first node of the node cluster, the flow ownership and assigning, by the first node of the node cluster, the flow ownership to the second node of the node cluster.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Inventors: Laxmikantha Reddy Ponnuru, Arul Murugan Manickam, Michael David Tracy, Kannan Kumar, Hamzah Kardame
  • CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
    Publication number: 20220281815
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Application
    Filed: April 29, 2022
    Publication date: September 8, 2022
    Inventors: Sridharan RAJAGOPAL, Mahanandeesha S. HALLUR, Purushottam DEWANG, Kannan MURUGAN, Durga Prasanna KUMAR C.H., Pravin IYER, Chandrika MULAKALA, Dhanalakshmi SIVANANDHAN, Sreekala NAIR, Mohd ZAINUDDIN, Subramanyam Janardhan TANTRY, Chandru GAJENDRAN, Sriram RAJAGOPAL
  • Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
    Patent number: 11352322
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: June 7, 2022
    Assignee: Jubilant Epicore LLC
    Inventors: Sridharan Rajagopal, Mahanandeesha S. Hallur, Purushottam Dewang, Kannan Murugan, Durga Prasanna Kumar C. H., Pravin Iyer, Chandrika Mulakala, Dhanalakshmi Sivanandhan, Sreekala Nair, Mohd Zainuddin, Subramanyam Janardhan Tantry, Chandru Gajendran, Sriram Rajagopal
  • CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
    Publication number: 20200308110
    Abstract: The present disclosure describes novel compounds of the general Formula (I), their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs thereof. These compounds can inhibit both LSD and HDAC and are useful as therpeautic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, schizophrenia, Alzheimer's disease, parkinson's disease and the like.
    Type: Application
    Filed: May 8, 2017
    Publication date: October 1, 2020
    Inventors: Sridharan RAJAGOPAL, Mahanandeesha S. HALLUR, Purushottam DEWANG, Kannan MURUGAN, Durga Prasanna KUMAR C.H., Pravin IYER, Chandrika MULAKALA, Dhanalakshmi SIVANANDHAN, Sreekala NAIR, Mohd ZAINUDDIN, Subramanyam Janardhan TANTRY, Chandru GAJENDRAN, Sriram RAJAGOPAL
  • Triaminopyrimidine compounds useful for preventing or treating malaria
    Patent number: 9957253
    Abstract: The present invention relates to triaminopyrimidines and to pharmaceutically acceptable salts thereof, to their use in the treatment and/or prevention of malaria caused by plasmodium species, and to their methods of preparation.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: May 1, 2018
    Assignee: MMV MEDICINES FOR MALARIA VENTURE
    Inventors: Shahul Hameed Peer Mohamed, Vikas Patil, Kannan Murugan, Eknath Vithalrao Bellale, Anandkumar Raichurkar, Sudhir Landge, Jayashree Puttur, Nilanjana Roy Choudhury, Gajanan Shanbhag, Krishna Koushik, Pravin Iyer, Vasan Kirthika Sambandamurthy, Suresh Solapure, Shridhar Narayanan
  • TRIAMINOPYRIMIDINE COMPOUNDS USEFUL FOR PREVENTING OR TREATING MALARIA
    Publication number: 20170050951
    Abstract: The present invention relates to triaminopyrimidines and to pharmaceutically acceptable salts thereof, to their use in the treatment and/or prevention of malaria caused by plasmodium species, and to their methods of preparation.
    Type: Application
    Filed: March 26, 2015
    Publication date: February 23, 2017
    Inventors: SHAHUL HAMEED PEER MOHAMED, VIKAS PATIL, KANNAN MURUGAN, EKNATH VITHALRAO BELLALE, ANANDKUMAR RAICHURKAR, SUDHIR LANDGE, JAYASHREE PUTTUR, NILANJANA ROY CHOUDHURY, GAJANAN SHANBHAG, KRISHNA KOUSHIK, PRAVIN IYER, VASAN KIRTHIKA SAMBANDAMURTHY, SURESH SOLAPURE, SHRIDHAR NARAYANAN